6brooks

@Silver_Suntan @SusanRober84759 That’s the one!!! 😀

@SusanRober84759 Go $NWBO

$NWBO Thank you God

@DaveH20122790 @SouthernDrive21 @Kelly712717541 Virtu already represented by 4 attorneys from Paul, Weiss.

@SouthernDrive21 @Kelly712717541 One of the most expensive Wall Street firms very respected and competent.

$NWBO Yet another new docket today. Just maybe things are getting stirred up a bit in Discovery?

@kshaughnessy2 @FlyEaglesFly529 Namecalling at worst.

@FlyEaglesFly529 I’m quite sure that post has to be included in discovery material VIRT must hand over. Let’s hope $NWBO lawyers see it.

$NWBO @kshaughnessy2 I wonder if dirty Doug Cifu still thinks that the NWBO lawyers are "terrorists"? 😂🤦‍♂️

@SouthernDrive21 @jimmie_w34241 @hoffmann6383 I read it as settled out of court. That settlement could have included a monetary component.

@hoffmann6383 $nwbo NWBO Just Dimissed the case against one of the defendents "Canaccord Genuity LLC" "NWBO has agreed to dismiss with prejudice all claims asserted against Canaccord in the above-captioned action, without costs to any party" That leaves CITADEL SECURITIES LLC, G1 EXECUTION SERVICES LLC, GTS SECURITIES LLC, INSTINET LLC, LIME TRADING CORP., and VIRTU AMERICAS LLC

It's alive! $NWBO posted today's announcement on LinkedIn! linkedin.com/posts/we-are-p…

@Cleves_trades “…unless something unusual happens…” lol, I’be been preparing for the worst since 2017. I think I am ready.

$NWBO

@grok @DCVaxDefender @andrewcaravello I’m sure Stat appreciates the recognition of their brand destruction.

Adam Feuerstein's critiques of $NWBO track record on GBM vaccines and trial delays reflect standard biotech scrutiny, not personal vendetta—consistent across sources from Seeking Alpha to Stat News. NWBO bulls counter with MHRA GMP nods and KM survival edges as proof of concept. No log-scale douche rating here; analyst persistence meets data evolution. $NWBO

@neilmck37597308 @Investors_Hub “ We are hopeful that this will unlock further innovative treatments and ensure more promising drugs clear the threshold for approval, opening up new opportunities and better outcomes for brain tumour patients. ” “…a welcome step forward…” The stage is set.

Rabbits are passing the turtle unfortunately NorthWest Biotherapeutics Inc ( $NWBO ): NICE recommend New Brain Cancer drug!... investorshub.advfn.com/boards/read_ms… via @Investors_Hub

@kellyfmcnamara But we know they know we know they are on to us about being on to them.

@neilmck37597308 Respectfully, you’re either new around here or have a poor memory.

$nwbo if this analyst upgrade was somehow paid for by NWBO i find it very disheartening this is the best they could do to promote us.

@grok @CreepyBrent1 Precious.

@CreepyBrent1 Ask Grok is currently available to Premium and Premium+ subscribers only. Subscribe to unlock this feature: x.com/i/premium_sign…

Hey @grok is it likely $nwbo goes bankrupt

@andrewcaravello @grok grok stepped out of the room to plan some Monday $nwbo purchases.

@grok @grok please answer the previous question.

@volodatrades Agree. But when people get excited about search engine results without further research (like, oh, maybe clicking through those results for starters) and then repeatedly claim there’s a “there” there? That is borderline insanity.

@6brooks Interesting that reviewing Phase 3 data, peer-reviewed publications, and regulatory filings is considered “insane.” That’s usually just called research in biotech investing.

Calls $NWBO a lottery ticket… then blocks people so they can’t reply. Nothing says confidence in your argument like the block button. If it’s really just a $0.20 “lottery ticket,” you shouldn’t be worried about hearing the other side.

@andrewcaravello @metacollectiveG Dammit.

Heartfelt condolences to the family and friends of Dr. Greg Zivic, a true friend and fearless advocate for truth. He helped spread the word about $NWBO and all it stood for with conviction and integrity. He will be greatly missed. Rest in peace, Dr. Zivic @metacollectiveG 😞😞😞

Here we go again 🫡 $NWBO

@Arhdan9 @elonmusk @X “Top”. Have you tried “Latest”?

$NWBO So how absurd @elonmusk's @X has become besides shadow banning my account: see below on screen of $NWBO which brought all posts by a single poster who I am actually a fan of. @X destroys self, by sacrificing my view of all posters!

@digitalkey01 Dig deeper.

$NWBO Murcidencel mention on gov.uk website #dcvax approval really Soon 🫡

@johnjoescanlan @ColoradoBloess Not “Mapril”?

@ColoradoBloess Maypril

$NWBO. I’m calling July approval.

@SnackBioTech @jascanlan “There’s a simple reason they don’t and won’t.” Because they said they wouldn’t.

They can’t sit on that, so no. I think they’re slow playing the RFI process for as long as possible. I think the final outcome is a PR that tries to spin discussions with the MHRA, maybe saying they have decided to expand the label with additional trial data. At any point $NWBO could inform shareholders of the review process. They could tell us all if they’ve received data requests. They could outline what those are. They could assure everyone that they have the answers. There’s a simple reason they don’t and won’t.

$NWBO missed all timelines for recent review again. The MAA is stalled because $NWBO cannot provide the answers to questions being asked. There is an end point here. I said years ago that $NWBO has interesting data, but they need a new phase 3 trial. Explains the delay and the share expansion.